Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2025 ,inter alia, to consider and approve Intimation for Board Meeting held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 4.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kabra Drugs Ltd has informed BSE that its Board of Directors will meet on October 8, 2025, at the Chennai office. The key agenda is to consider and approve the final draft of a Share Purchase Agreement (SPA) for acquiring AMR Pharma India Private Limited. The Board will also discuss steps to execute the agreement and complete the transaction. Additionally, the Board plans to broadbase itself by inducting new technical people. The meeting may also take up any other agenda items with the Chair's permission.
This is a significant corporate development for Kabra Drugs shareholders — if approved, the acquisition of AMR Pharma India could expand the company's business footprint in the pharma sector. Investors should watch for the post-meeting outcome, deal valuation, and whether the acquisition triggers any open-offer obligation under SEBI takeover norms.